What is the current Price Target for the Cortexyme, Inc. stock?

The average Cortexyme, Inc. target price is $77.52. This is 158.40% higher than the current stock price. The highest price target is 243.00%, the lowest is 128.93%. 6 Analysts have issued a price target Cortexyme, Inc. 2027 .

How high will the Cortexyme, Inc. stock rise?

No reliable answer can be given as to how high the Cortexyme, Inc. stock will rise. The performance of stocks, including the Cortexyme, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Cortexyme, Inc. stock today?

The performance of Cortexyme, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Cortexyme, Inc. stock fall?

The decline in Cortexyme, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cortexyme, Inc. Forecast, price target & analysts

$29.98

0.07%

Nasdaq, Sep 25, 12:20 pm EDT. Market open.

ISIN

US22053A1079

Symbol

QNCX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Cortexyme, Inc. Target price 2026 - Analyst rating & recommendation

Cortexyme, Inc. Classifications & Recommendation

Buy

69%

Hold

31%

Cortexyme, Inc. Price Target

Target Price	$77.52
Price	$30.00
Potential	158.40% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Cortexyme, Inc. 2027 . The average Cortexyme, Inc. target price is $77.52. This is 158.40% register free of charge higher than the current stock price. The highest price target is $102.90 243.00% register free of charge , the lowest is $68.68 128.93% register free of charge .
	A rating was issued by 13 analysts: 9 Analysts recommend Cortexyme, Inc. to buy, 4 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cortexyme, Inc. stock has an average upside potential 2027 of 158.40% register free of charge . Most analysts recommend the Cortexyme, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-335.27	-8.26
	27.62%	97.54%
P/E		negative

7 Analysts have issued a Cortexyme, Inc. forecast for earnings per share. The average Cortexyme, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-335.27	27.62%
2026	$-8.26 97.54% unlock
2027	$-4.55 44.92% unlock
2028	$-4.19 7.91% unlock
2029	$-5.55 32.46% unlock
2030	$-5.31 4.32% unlock
2031	$-8.03 51.22% unlock
2032	$-0.11 98.63% unlock
2033	$3.28 3,081.82% unlock

Current	-1.99	30.64%
2026	-3.63 82.35% unlock
2027	-6.59 81.54% unlock
2028	-7.16 8.65% unlock
2029	-5.41 24.44% unlock
2030	-5.65 4.44% unlock
2031	-3.74 33.81% unlock
2032	-267.38 7,049.20% unlock
2033	9.13 103.41% unlock

Cortexyme, Inc....

Current Cortexyme, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citizens	Locked ➜ Locked	Locked	Sep 22 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Aug 18 2026
Oppenheimer	Locked ➜ Locked	Locked	Jul 29 2026
Leerink Partners	Locked ➜ Locked	Locked	Jun 24 2026
Cantor Fitzgerald	Locked ➜ Locked	Locked	Jun 23 2026
D. Boral Capital	Locked ➜ Locked	Locked	Jan 30 2026
Citizens	Locked ➜ Locked	Locked	Jan 30 2026

Analyst Rating	Date
Locked Citizens: Locked ➜ Locked	Sep 22 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Aug 18 2026
Locked Oppenheimer: Locked ➜ Locked	Jul 29 2026
Locked Leerink Partners: Locked ➜ Locked	Jun 24 2026
Locked Cantor Fitzgerald: Locked ➜ Locked	Jun 23 2026
Locked D. Boral Capital: Locked ➜ Locked	Jan 30 2026
Locked Citizens: Locked ➜ Locked	Jan 30 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 48.83%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now